Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issuesResults allow for compari ...
AEVEX Corp. (NYSE: AVEX) is presenting its comprehensive portfolio of autonomous systems, launched effects, airborne ISR, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results